AxoGen (AXGN)
(Delayed Data from NSDQ)
$9.18 USD
+0.52 (6.00%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $9.17 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Price, Consensus and EPS Surprise
AXGN 9.18 +0.52(6.00%)
Will AXGN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AXGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AXGN
AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?
AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection
AXGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
Other News for AXGN
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
AxoGen announces full launch of Avive+ Soft Tissue Matrix
AXGN Makes Notable Cross Below Critical Moving Average
AxoGen’s Annual Meeting Decisions and Director Changes
Axogen Breaks Above 200-Day Moving Average - Bullish for AXGN